Response to 13C-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients [2]

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 2, 2006, Pages 253-254

  Banasch, Matthias ^a   Goetze, Oliver ^a   Kollar, Susanne ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CARBON 13; CARBON DIOXIDE; METHIONINE; METHIONINE C 13; UNCLASSIFIED DRUG;

BREATH ANALYSIS; CARBON DIOXIDE EXCRETION; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER MITOCHONDRION; METHIONINE C 13 BREATH TEST; MITOCHONDRIAL TOXICITY; NON INVASIVE MEASUREMENT; PATIENT; PRIORITY JOURNAL; THERAPY NAIVE PATIENT; TREATMENT FAILURE;

EID: 33646035521     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000195609.32885.71     Document Type: Letter

References (2)

1. Banasch M, Goetze O, Hollborn I, et al. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr. 2005;40:149-154.
2. 13C] methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother. 2005;55:84-89.